Pipeline Growth Dropped Sharply in 2017 But Size Tops 15K
Executive Summary
The number of products in active development by the pharma and biotech industries has topped 15,000 for the first time but the rate of the pipeline growth has slowed to just 2.7%, the lowest for five years, shows a new analysis by Citeline.